{
  "item1": "Life Sciences Applied Markets Customers approximately 52,000 customers life sciences applied markets business fiscal year 2024. significant number life sciences applied markets customers also customers Agilent CrossLab business. life sciences applied markets business susceptible seasonality its orders revenues primarily related U.S. foreign government budgets, chemicals advanced materials environmental customers large pharmaceutical company budgets.",
  "item7": "Research development expenses decreased 9 percent 2024 when compared 2023. Research development expenses decreased primarily due lower expenses attributed business exit activities salary expenses related workforce reduction activities. Research development expenses increased 2 percent 2023 when compared 2022. Research development expenses increased due higher wages, additional expenses related recent acquisition higher infrastructure costs.",
  "item2": "revenue, costs expenses, monetary assets liabilities equity exposed changes foreign currency exchange rates result global operating financing activities. overall effect changes foreign currency exchange rates no impact revenue growth nine months ended July 31, 2025 when compared same period last year. Typically, when movements foreign currency exchange rates positive impact revenue, they will also negative impact increasing costs expenses vice versa. calculate impact movements foreign currency exchange rates applying actual foreign currency exchange rates effect during last month each quarter current year both applicable current prior year periods."
}